QIM
NVRO

Quantitative Investment Management’s NEVRO CORP. NVRO Stock Holding History

Quantitative Investment Management’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-4,900
Closed -$391K – 921
2018
Q2 		$391K Buy
+4,900
New +$406K 0.01% 635

Other funds holding NVRO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Quantitative Investment Management's NVRO Position: Q3 2018 in Review

Quantitative Investment Management sold out of NEVRO CORP. (NVRO) in Q3 2018, closing a stake of 4,900 shares — an estimated $391K sold.

Quantitative Investment Management first reported a position in NVRO in Q2 2018 and held it in 1 quarter. The position peaked at $391K in Q2 2018. 171 funds tracked by Wall St. Rank hold NVRO as of Q3 2018.

  • Quantitative Investment Management reported no remaining NEVRO CORP. position as of Q3 2018 after selling out during the quarter.
  • Quantitative Investment Management sold 4,900 NEVRO CORP. shares in Q3 2018, an estimated $391K.
  • Quantitative Investment Management first reported a position in NEVRO CORP. in Q2 2018 and held it in 1 quarter.
  • Quantitative Investment Management's NEVRO CORP. position peaked at $391K in Q2 2018.
  • 171 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2018.

Based on Quantitative Investment Management's 13F filing for Q3 2018, filed 14 Nov 2018.